The estimated Net Worth of Laurie H M.D. Glimcher is at least $2.72 Million dollars as of 8 March 2024. Laurie Glimcher owns over 1,228 units of Analog Devices stock worth over $1,070,883 and over the last 19 years he sold ADI stock worth over $1,652,430. In addition, he makes $0 as Independent Director at Analog Devices.
Laurie has made over 20 trades of the Analog Devices stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 1,228 units of ADI stock worth $276,386 on 8 March 2024.
The largest trade he's ever made was exercising 11,000 units of Analog Devices stock on 30 January 2013 worth over $281,600. On average, Laurie trades about 1,141 units every 82 days since 2006. As of 8 March 2024 he still owns at least 4,758 units of Analog Devices stock.
You can see the complete history of Laurie Glimcher stock trades at the bottom of the page.
Dr. Laurie H. Glimcher M.D. serves as Independent Director of the Company. Dr. Glimcher speaks nationally and internationally on cancer, immunology, skeletal biology, and translational medicine, and has contributed more than 350 scholarly articles and papers to the medical literature. She also currently serves on the Board of Directors at GlaxoSmithKline Pharmaceutical Corporation. In addition to a number of senior leadership roles held at both Harvard Medical School and Harvard School of Public Health from 1982 to present, she has also served as the Stephen and Suzanne Weiss Dean and Professor of Medicine of Weill Cornell Medicine and Provost for Medical Affairs of Cornell University. She is a member of the Board of Trustees at the Dana-Farber Cancer Institute and a member of the US National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences and the American Philosophical Society. She previously served on the Board of Directors of Bristol-Myers Squibb Pharmaceutical Corporation and Waters Corporation. She is also the recipient of many awards and honors. In 2018, she received the American Association of Immunologists Lifetime Achievement Award; the Indiana University School of Medicine's Steven C. Beering Award for outstanding research contributions to advancement of biomedical or clinical science; and the L'Oréal-UNESCO Award for Women in Science. She has also received the 2017 George M. Kober Medal and the 2017 Award for Distinguished Research in the Biomedical Sciences from the Association of American Medical Colleges (AAMC). Dr. Glimcher is a magna cum laude graduate of Radcliffe College, and holds an MD degree cum laude from Harvard Medical School.
Laurie Glimcher is 68, he's been the Independent Director of Analog Devices since 2020. There are 4 older and 22 younger executives at Analog Devices. The oldest executive at Analog Devices Inc. is Dr. Raymond S. Stata Ph.D., 87, who is the Founder & Chairman.
Over the last 23 years, insiders at Analog Devices have traded over $165,706,606 worth of Analog Devices stock and bought 79,667 units worth $7,085,991 . The most active insiders traders include Bruce R Evans, Lisa T Su und Tracy S Keogh. On average, Analog Devices executives and independent directors trade stock every 9 days with the average trade being worth of $2,266,230. The most recent stock trade was executed by Vincent Roche on 3 September 2024, trading 10,000 units of ADI stock currently worth $911,300.
Analog Devices, Inc., also known simply as Analog, is an American multinational semiconductor company specializing in data conversion, signal processing, and power management technology, headquartered in Wilmington, Massachusetts.
Analog Devices executives and other stock owners filed with the SEC include: